LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

Kodu・Aktsiate loetelu・Avidity Biosciences Inc

Avidity Biosciences Inc

Suletud

SektorTervishoid

15.05

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

15.05

Max

15.05

Põhinäitajad
By Trading Economics
Sissetulek	-63M -237M
Müük	-12M 860K
Aktsiakasum	-1.27
Kasumimarginaal	-27,569.884
Töötajad	511
EBITDA	-59M -232M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	-0.1% downside

Turustatistika
By TradingEconomics
Turukapital	-9B 2.3B
Eelmine avamishind	15.05
Eelmine sulgemishind	15.05

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

25.575 / 32.65 Toetus ja vastupanu

Avidity Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. märts 2026, 23:01 UTC

Tulu

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5. märts 2026, 21:54 UTC

Tulu

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5. märts 2026, 21:35 UTC

Suurimad hinnamuutused turgudel

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5. märts 2026, 23:46 UTC

Market Talk

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5. märts 2026, 23:33 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5. märts 2026, 23:27 UTC

Market Talk

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5. märts 2026, 22:54 UTC

Market Talk

Tulu

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5. märts 2026, 22:50 UTC

Market Talk

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5. märts 2026, 22:48 UTC

Tulu

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5. märts 2026, 22:46 UTC

Tulu

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5. märts 2026, 22:44 UTC

Tulu

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5. märts 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5. märts 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

5. märts 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

5. märts 2026, 21:35 UTC

Tulu

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5. märts 2026, 21:32 UTC

Tulu

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5. märts 2026, 21:26 UTC

Tulu

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5. märts 2026, 21:24 UTC

Tulu

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5. märts 2026, 21:23 UTC

Tulu

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5. märts 2026, 21:22 UTC

Tulu

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5. märts 2026, 21:21 UTC

Tulu

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5. märts 2026, 21:21 UTC

Tulu

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5. märts 2026, 21:20 UTC

Tulu

Costco February Net Sales Were $21.69 B >COST

5. märts 2026, 21:20 UTC

Tulu

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5. märts 2026, 21:20 UTC

Tulu

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5. märts 2026, 21:19 UTC

Tulu

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5. märts 2026, 21:18 UTC

Tulu

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5. märts 2026, 21:18 UTC

Tulu

Costco 2Q Same-Store Sales Up 7.4% >COST

5. märts 2026, 21:15 UTC

Tulu

Costco 2Q EPS $4.58 >COST

Võrdlus sarnastega

Hinnamuutus

Avidity Biosciences Inc Prognoos

Hinnasiht

By TipRanks

-0.1% langus

12 kuu keskmine prognoos

Keskmine 72.75 USD -0.1%

Kõrge 75 USD

Madal 72 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Avidity Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Avidity Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

25.575 / 32.65Toetus ja vastupanu

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Recent bearish events outweigh bullish events.

Finantsandmed

Ettevõttest Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.